• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本大阪地区 COVID-19 的临床特征:与第四波相比,前-第三波的比较。

Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first-third waves with the fourth wave.

机构信息

Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan; Department of Infectious Diseases, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.

Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.

出版信息

Respir Investig. 2021 Nov;59(6):810-818. doi: 10.1016/j.resinv.2021.08.005. Epub 2021 Sep 10.

DOI:10.1016/j.resinv.2021.08.005
PMID:34565716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8429365/
Abstract

BACKGROUND

The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first-third waves and the fourth wave.

METHODS

We performed an observational retrospective study of COVID-19 cases at the National Hospital Organization Kinki-Chuo Chest Medical Center.

RESULTS

We identified 404 patients (median age: 71.0 years [interquartile range: 56.0-80.0]), of whom 199 (49.1%) had mild disease, 142 (35.2%) had moderate disease, and 63 (15.6%) had severe disease. The overall mortality rate was 5.4% (22/404). Based on multivariate logistic regression analysis, cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were independent risk factors for moderate to severe disease. For every 1 mg/dL increase in C-reactive protein, 10 IU/L increase in lactate dehydrogenase, and 100 ng/mL increase in ferritin, the risk for moderate to severe disease increased by 18.3%, 12.9%, and 8.9%, respectively. Overall disease severity in the fourth wave was higher than in the first-third waves. However, there was no significant difference in mortality. Because of a shortage of beds, four of the 28 severe patients (14.3%) in the fourth wave could not be transferred to the advanced hospital.

CONCLUSIONS

Cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were risk factors for moderate to severe COVID-19 in our cohort. During the fourth wave, COVID-19 severity worsened, increasing the number of patients who could not be transferred to beds for severe cases, resulting in a medical crisis in Osaka.

摘要

背景

日本大阪府的第四波 COVID-19 疫情导致了医疗危机。在这里,我们旨在确定 COVID-19 严重程度的危险因素,并将前三个波次和第四波次的患者进行比较。

方法

我们对日本国立医院组织近畿中部胸科医疗中心的 COVID-19 病例进行了一项观察性回顾性研究。

结果

我们共确定了 404 名患者(中位年龄:71.0 岁[四分位间距:56.0-80.0]),其中 199 名(49.1%)为轻症,142 名(35.2%)为中度,63 名(15.6%)为重症。总死亡率为 5.4%(22/404)。基于多变量逻辑回归分析,心血管疾病、发热、呼吸困难和几种炎症生物标志物是中重度疾病的独立危险因素。C 反应蛋白每增加 1mg/dL、乳酸脱氢酶增加 10IU/L、铁蛋白增加 100ng/mL,中重度疾病的风险分别增加 18.3%、12.9%和 8.9%。第四波次的整体疾病严重程度高于前三个波次,但死亡率没有显著差异。由于床位短缺,第四波次的 28 名重症患者中有 4 名(14.3%)无法转至高级医院。

结论

心血管疾病、发热、呼吸困难和几种炎症生物标志物是我们队列中中重度 COVID-19 的危险因素。在第四波次期间,COVID-19 的严重程度恶化,导致无法转至重症病床的患者数量增加,从而导致大阪出现医疗危机。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503a/8429365/d9a8230b56fc/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503a/8429365/98f037878dc2/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503a/8429365/a26e462a99ba/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503a/8429365/d9a8230b56fc/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503a/8429365/98f037878dc2/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503a/8429365/a26e462a99ba/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/503a/8429365/d9a8230b56fc/gr3_lrg.jpg

相似文献

1
Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first-third waves with the fourth wave.日本大阪地区 COVID-19 的临床特征:与第四波相比,前-第三波的比较。
Respir Investig. 2021 Nov;59(6):810-818. doi: 10.1016/j.resinv.2021.08.005. Epub 2021 Sep 10.
2
Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China.中国浙江连续三代传播的 COVID-19 患者的临床特征。
Clin Microbiol Infect. 2020 Oct;26(10):1380-1385. doi: 10.1016/j.cmi.2020.06.018. Epub 2020 Jun 25.
3
Coronavirus disease 19 (Covid-19): A comparative study of pattern of liver injury in adult patients in different waves of Covid-19 infection.冠状病毒病19(新冠肺炎):不同波次新冠肺炎感染成年患者肝损伤模式的比较研究
Arab J Gastroenterol. 2024 May;25(2):170-175. doi: 10.1016/j.ajg.2024.01.008. Epub 2024 Feb 19.
4
[Characteristics and courses of COVID-19 in patients from the first through fifth waves of the disease: Focused on a single public health center in Tokyo, Japan].[新型冠状病毒肺炎第一至五波疫情中患者的特征及病程:以日本东京一家公共卫生中心为重点]
Nihon Koshu Eisei Zasshi. 2024 Feb 20;71(2):117-123. doi: 10.11236/jph.23-077. Epub 2023 Nov 27.
5
Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.137 例 COVID-19 死亡患者的临床特征和免疫反应:一项回顾性研究。
Front Cell Infect Microbiol. 2020 Dec 7;10:595333. doi: 10.3389/fcimb.2020.595333. eCollection 2020.
6
COVID-19 in three waves in a tertiary referral hospital in Belgium: a comparison of patient characteristics, management, and outcome.比利时一家三级转诊医院的三波 COVID-19:患者特征、治疗和结局比较。
Virol J. 2024 May 30;21(1):119. doi: 10.1186/s12985-024-02360-8.
7
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
8
Delirium in Patients with COVID-19 in Japan.日本新冠肺炎患者的谵妄
Intern Med. 2022 Oct 1;61(19):2861-2866. doi: 10.2169/internalmedicine.9013-21. Epub 2022 Feb 26.
9
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.美国 31461 例 COVID-19 成年人死亡相关合并症:一项联合电子病历分析。
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.
10
The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.COVID-19 合并症网络在韩国住院患者中的解剖学研究。
Epidemiol Health. 2021;43:e2021035. doi: 10.4178/epih.e2021035. Epub 2021 May 7.

引用本文的文献

1
Changes in Characteristics and Outcomes of Newly Initiated Physician-Led Home Visit Care Before and During the Coronavirus Disease 2019 Pandemic: A Multicenter Retrospective Study in Japan.2019年冠状病毒病大流行之前及期间新开展的由医生主导的家访护理的特征和结局变化:日本的一项多中心回顾性研究
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251354832. doi: 10.1177/21501319251354832. Epub 2025 Jul 17.
2
Changes in proportions of Cesarean section before and during the COVID-19 pandemic in Japan.日本在新冠疫情之前及期间剖宫产比例的变化。
J Obstet Gynaecol Res. 2025 Jul;51(7):e16370. doi: 10.1111/jog.16370.
3

本文引用的文献

1
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.丹麦与感染 SARS-CoV-2 谱系 B.1.1.7 相关的住院风险:一项观察性队列研究。
Lancet Infect Dis. 2021 Nov;21(11):1507-1517. doi: 10.1016/S1473-3099(21)00290-5. Epub 2021 Jun 23.
2
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.变异新冠病毒株 B.1.1.7 患者的住院风险:队列分析。
BMJ. 2021 Jun 15;373:n1412. doi: 10.1136/bmj.n1412.
3
Characteristics of patients with novel coronavirus disease (COVID-19) during the first surge versus the second surge of infections in Osaka Prefecture, Japan.
Clinical characteristics of coronavirus disease 2019 in patients undergoing laparoscopic bariatric/metabolic surgery: a nationwide survey in Japan.
接受腹腔镜减肥/代谢手术患者的2019冠状病毒病临床特征:日本全国性调查
Surg Today. 2025 May;55(5):668-675. doi: 10.1007/s00595-024-02967-y. Epub 2024 Dec 3.
4
Change in the Proportion of Death at Home during the COVID-19 Pandemic and Its Associated Factors in the Municipality Level: A Nationwide Study in Japan.新冠疫情期间日本市级层面在家中死亡比例的变化及其相关因素:一项全国性研究
JMA J. 2024 Apr 15;7(2):213-221. doi: 10.31662/jmaj.2023-0165. Epub 2024 Mar 18.
5
Descriptive epidemiology of COVID-19 in Japan 2020: insights from a multihospital database.2020年日本新型冠状病毒肺炎的描述性流行病学:来自多医院数据库的见解
Ann Clin Epidemiol. 2022 Sep 29;5(1):5-12. doi: 10.37737/ace.23002. eCollection 2023.
6
Changes in the place of death before and during the COVID-19 pandemic in Japan.日本在 COVID-19 大流行前后死亡地点的变化。
PLoS One. 2024 Feb 28;19(2):e0299700. doi: 10.1371/journal.pone.0299700. eCollection 2024.
7
Influence of the COVID-19 Outbreak in Vulnerable Patients (Pediatric Patients, Pregnant Women, and Elderly Patients) on an Emergency Medical Service System: A Pre- and Post-COVID-19 Pandemic Comparative Study Using the Population-Based ORION Registry.COVID-19 疫情对脆弱患者(儿科患者、孕妇和老年患者)对紧急医疗服务系统的影响:基于人群的 ORION 登记处的 COVID-19 大流行前后比较研究。
Medicina (Kaunas). 2024 Feb 19;60(2):345. doi: 10.3390/medicina60020345.
8
Characteristics and in-hospital mortality of patients with COVID-19 from the first to fifth waves of the pandemic in 2020 and 2021 in the Japanese Medical Data Vision database.日本医疗数据视野数据库中2020年至2021年新冠疫情第一波至第五波期间新冠肺炎患者的特征及院内死亡率。
Heliyon. 2023 Aug 25;9(9):e19490. doi: 10.1016/j.heliyon.2023.e19490. eCollection 2023 Sep.
9
COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy.患有间质性肺疾病的COVID-19患者:基于类固醇的治疗策略的潜在价值。
J Clin Med. 2023 Jul 27;12(15):4940. doi: 10.3390/jcm12154940.
10
Factors associated with COVID-19 length of hospitalization and mortality during four epidemic waves, March 2020-November 2021, Suriname.2020年3月至2021年11月,苏里南四个疫情波次期间与新冠病毒病住院时长及死亡率相关的因素
Rev Panam Salud Publica. 2023 Jun 30;47:e100. doi: 10.26633/RPSP.2023.100. eCollection 2023.
日本大阪府新型冠状病毒病(COVID-19)患者在首次感染高峰与第二次感染高峰期间的特征。
Glob Health Med. 2021 Apr 30;3(2):82-89. doi: 10.35772/ghm.2020.01102.
4
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.关注的 SARS-CoV-2 变体 B.1.1.7、B.1.351 或 P.1 的特征:来自七个欧盟/欧洲经济区国家的数据,2020 年第 38 周至 2021 年第 10 周。
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.
5
Clinical characteristics of Japanese patients with moderate to severe COVID-19.伴有中重度 COVID-19 的日本患者的临床特征。
J Infect Chemother. 2021 Jun;27(6):895-901. doi: 10.1016/j.jiac.2021.02.028. Epub 2021 Mar 4.
6
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.社区检出的 SARS-CoV-2 谱系 B.1.1.7 病例死亡率增加。
Nature. 2021 May;593(7858):270-274. doi: 10.1038/s41586-021-03426-1. Epub 2021 Mar 15.
7
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.202012/1 感染关注的 SARS-CoV-2 变异株的患者的死亡率风险:匹配队列研究。
BMJ. 2021 Mar 9;372:n579. doi: 10.1136/bmj.n579.
8
Characteristics of COVID-19 patients admitted into two hospitals in sapporo, Japan: Analyses and insights from two outbreak waves.日本札幌两家医院收治的 COVID-19 患者的特征:两次疫情暴发期间的分析与见解。
Respir Investig. 2021 Mar;59(2):180-186. doi: 10.1016/j.resinv.2020.11.008. Epub 2021 Jan 1.
9
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
10
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.